Two Cases of Interferon-Alpha-Induced Sarcoidosis Koebnerized along Venous Drainage Lines: New Pathogenic Insights and Review of the Literature of Interferon-Induced Sarcoidosis.

Détails

ID Serval
serval:BIB_C5ABDE4F5C22
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
Titre
Two Cases of Interferon-Alpha-Induced Sarcoidosis Koebnerized along Venous Drainage Lines: New Pathogenic Insights and Review of the Literature of Interferon-Induced Sarcoidosis.
Périodique
Dermatology
Auteur⸱e⸱s
Buss G., Cattin V., Spring P., Malinverni R., Gilliet M.
ISSN
1421-9832 (Electronic)
ISSN-L
1018-8665
Statut éditorial
Publié
Date de publication
2013
Volume
226
Numéro
4
Pages
289-297
Langue
anglais
Notes
Publication types: Journal ArticlePublication Status: ppublishDocument Type: Case and Review
Résumé
Sarcoidosis is a systemic granulomatous disorder of unknown origin commonly affecting the lung, the lymphoid system and the skin. We report here two cases of cutaneous sarcoidosis in two former intravenous drug users following interferon (IFN)-α and ribavirin therapy for chronic hepatitis C. Both patients developed skin sarcoidosis along venous drainage lines of both forearms, coinciding with the areas of prior drug injections. The unique distribution of the skin lesions suggests that tissue damage induced by repeated percutaneous drug injections represents a trigger for the local skin manifestation of sarcoidosis. Interestingly, skin damage was recently found to induce the local expression IFN-α, a well-known trigger of sarcoidosis in predisposed individuals. Here we review the literature on sarcoidosis elicited in the context of IFN-α therapy and propose a new link between the endogenous expression of IFN-α and the induction of disease manifestations in injured skin. © 2013 S. Karger AG, Basel.
Pubmed
Web of science
Open Access
Oui
Création de la notice
17/10/2013 17:39
Dernière modification de la notice
20/08/2019 16:41
Données d'usage